Optiver Holding
LFCR icon

Optiver Holding’s Lifecore Biomedical LFCR Stock Holding History

Optiver Holding’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$923 Sell
248
-216
-47% -$1.49K ﹤0.01% 2073
2025
Q4 		$3.8K Hold
464
– – ﹤0.01% 1569
2025
Q3 		$3.42K Buy
+464
New +$3.51K ﹤0.01% 2082

Other funds holding LFCR

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Optiver Holding's LFCR Position: Q1 2026 in Review

Optiver Holding reduced its Lifecore Biomedical (LFCR) stake by 47% in Q1 2026, selling an estimated $1.49K and leaving 248 shares worth $923. The position accounts for ﹤0.01% of the portfolio, ranked #2073.

Optiver Holding first reported a position in LFCR in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.8K in Q4 2025. 105 funds tracked by Wall St. Rank hold LFCR as of Q1 2026.

  • Optiver Holding held 248 shares of Lifecore Biomedical worth $923 as of Q1 2026.
  • Optiver Holding sold 216 Lifecore Biomedical shares in Q1 2026, an estimated $1.49K.
  • Lifecore Biomedical made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #2073 holding.
  • Optiver Holding first reported a position in Lifecore Biomedical in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Lifecore Biomedical position peaked at $3.8K in Q4 2025.
  • 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.